ArticleMolecular therapy. Oncology2026
Arming oncolytic Coxsackievirus B3 with Neoleukin-2/15 enhances growth inhibition of colorectal carcinomas and induces T cell activation.
Leslie Elsner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.